Cargando…
Potential antiviral peptides targeting the SARS-CoV-2 spike protein
BACKGROUND: The coronavirus disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection became an international pandemic and created a public health crisis. The binding of the viral Spike glycoprotein to the human cell receptor angiotensin-converting enzyme 2 (ACE2)...
Autores principales: | Khater, Ibrahim, Nassar, Aaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716172/ https://www.ncbi.nlm.nih.gov/pubmed/36461109 http://dx.doi.org/10.1186/s40360-022-00627-w |
Ejemplares similares
-
In silico molecular docking analysis for repurposing approved antiviral drugs against SARS-CoV-2 main protease
por: Khater, Ibrahim, et al.
Publicado: (2021) -
Seeking antiviral drugs to inhibit SARS-CoV-2 RNA dependent RNA polymerase: A molecular docking analysis
por: Khater, Ibrahim, et al.
Publicado: (2022) -
SARS-CoV-2 variant surge and vaccine breakthrough infection: A computational analysis
por: Khater, Ibrahim, et al.
Publicado: (2022) -
A computational peptide model induces cancer cells’ apoptosis by docking Kringle 5 to GRP78
por: Khater, Ibrahim, et al.
Publicado: (2023) -
In silico design of antiviral peptides targeting the spike protein of SARS-CoV-2
por: Ling, Rongsong, et al.
Publicado: (2020)